You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 11月14日港股盤前

根據uSMART輿情監測數據,週末期間,市場關注指數最高的3只股票是新秀麗、復星醫藥、華潤置地。

11月14日—港股關注排行TOP3

輿情變化榜單

新秀麗

個股K線圖

關注度第一爲新秀麗,該股上個交易日收盤上漲3.44%,報於18.62港元。近5個交易日累計上漲3.44%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

新秀麗第三季轉虧爲盈、收入增逾4成 中國旅遊限制減慢復甦步伐

新秀麗第三季度銷售淨額增加42.0%至7.91億美元;固生堂與浙江金控集團等多方聯合簽署設立10億元級別中醫藥產業投資基金框架協議

復星醫藥

個股K線圖

關注度第二爲復星醫藥,該股上個交易日收盤上漲3.81%,報於23.15港元。近5個交易日累計下跌4.73%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

復星醫藥:子公司已出售BNTX 109.4899萬股普通股、出售金額共1.79億美元

復星醫藥減持BioTech股份 套現逾14億港元

華潤置地

個股K線圖

關注度第三爲華潤置地,該股上個交易日收盤上漲9.52%,報於30.50港元。近5個交易日累計上漲12.34%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

華潤置地10月總合同銷售274.億人民幣 增36.8%

華潤置地10月總合同銷售額同比增36.8%;固生堂與多方聯合簽署10億元級別中醫藥投資基金協議

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account